This page shows the publications co-authored by Robert Burakoff and Frederick Makrauer.
Blood-based biomarkers used to predict disease activity in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2015 May; 21(5):1132-40.
Blood-based biomarkers can differentiate ulcerative colitis from Crohn's disease and noninflammatory diarrhea. Inflamm Bowel Dis. 2011 Aug; 17(8):1719-25.
Differential regulation of peripheral leukocyte genes in patients with active Crohn's disease and Crohn's disease in remission. J Clin Gastroenterol. 2010 Feb; 44(2):120-6.
High self-efficacy predicts adherence to surveillance colonoscopy in inflammatory bowel disease. Inflamm Bowel Dis. 2014 Sep; 20(9):1602-10.
Factors that affect adherence to surveillance colonoscopy in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Mar; 19(3):534-9.
Doctor message can alter patients' behavior and attitudes regarding inflammatory bowel disease and colon cancer. Inflamm Bowel Dis. 2012 Aug; 18(8):1531-9.
5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine. Inflamm Bowel Dis. 2006 Apr; 12(4):251-7.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.